HCA HCA Healthcare PE ratio, current and historical analysis

?
Relative Growth: Rel. Growth: 81
Relative Strength: Rel. Strength: 33
Relative Valuation: Rel. Valuation: 86
Relative Profitability: Rel. Profitability: 46

The PE ratio for HCA Healthcare stock stands at 14.2 as of Aug 21, 2026. This is based on the current EPS of $30.23 and the stock price of $429.19 per share. A decrease of 8% has been seen in the P/E ratio compared to the average of 15.4 of the last 4 quarters.

HCA PE ratio history

How has HCA's PE ratio performed in the past

Over the last ten years, the average PE ratio of HCA Healthcare has been 13.09. The current 14.2 PE ratio is 8% above the historical average. Over the past ten years, HCA's PE ratio was at its highest in the Sep 2024 quarter at 18.03, with a price of $406.43 and an EPS of $22.54. The Jun 2022 quarter recorded the bottom point at 7.95, with a price of $168.06 and an EPS of $21.14.

Today
14.2
Average
13.09
Median
12.78
Minimum
7.95
Maximum
18.03

HCA Healthcare PE ratio by year

Maximum annual increase: 94.13% in 2012

Maximum annual decrease: -25.3% in 2016

Year PE ratio PE change Price EPS
2025 16.27 20.7% $466.86 $28.7
2024 13.48 -4.13% $300.15 $22.27
2023 14.06 13.85% $270.68 $19.25
2022 12.35 3.43% $239.96 $19.43
2021 11.94 -19.43% $256.92 $21.52
2020 14.82 2.99% $164.46 $11.1
2019 14.39 26.01% $147.81 $10.27
2018 11.42 -20.42% $124.45 $10.9
2017 14.35 45.98% $87.84 $6.12
2016 9.83 -25.3% $74.02 $7.53
2015 13.16 -22.91% $67.63 $5.14
2014 17.07 25.24% $73.39 $4.3
2013 13.63 64.81% $47.71 $3.5
2012 8.27 94.13% $30.17 $3.65
2011 4.26 N/A $22.03 $5.17

HCA Healthcare PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Jun 2026 12.9 -19.73% $389.89 $30.23
Mar 2026 16.07 -1.23% $473.24 $29.44
Dec 2025 16.27 -0.06% $466.86 $28.7
Sep 2025 16.28 2.26% $426.2 $26.18
Jun 2025 15.92 4.87% $383.1 $24.07
Mar 2025 15.18 12.61% $345.55 $22.76
Dec 2024 13.48 -25.24% $300.15 $22.27
Sep 2024 18.03 21.09% $406.43 $22.54
Jun 2024 14.89 -9.26% $321.28 $21.58
Mar 2024 16.41 16.71% $333.53 $20.33
Dec 2023 14.06 17.46% $270.68 $19.25
Sep 2023 11.97 -19.01% $245.98 $20.55
Jun 2023 14.78 12.91% $303.48 $20.54
Mar 2023 13.09 5.99% $263.68 $20.14
Dec 2022 12.35 20.84% $239.96 $19.43

HCA Price vs fair value

How does HCA's price compare to its estimated fair value based on its growth

HCA average PE ratio chart

What is the average PE ratio of HCA for the past years

Currently, HCA's PE ratio is greater than its 5 and 10-year historical averages, but it is below the 3-year average.

3-year avg
15.12
5-year avg
13.78
10-year avg
13.09
15-year avg
12.77

PE comparison

HCA Healthcare's P/E of 14.2 is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 24.4, HCA Healthcare's P/E is 42% lower.

HCA PE vs peers

What is HCA's PE ratio compared to its peers

Frequently asked questions

What is HCA Healthcare's PE ratio?

The price to earnings ratio for HCA stock as of Aug 21, 2026, stands at 14.2.

What is the 3-year average PE ratio for HCA Healthcare (HCA)?

Over the last 3 years, the average price to earnings ratio for HCA stock is 15.12.

What is the 5-year average PE ratio for HCA Healthcare (HCA)?

Over the last 5 years, the average price to earnings ratio for HCA stock is 13.78.

What is the highest PE ratio for HCA?

The highest quarterly PE ratio in the last ten years has been 18.03 and it was in the Sep 2024 quarter.

How does the current PE ratio for HCA compare to its historical average?

HCA's current price to earnings ratio is 8% above its 10-year historical average.

How is HCA's PE ratio calculated (HCA Healthcare PE ratio formula)?

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Aug 21, 2026), HCA Healthcare's stock price is $429.19. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $30.23. Therefore, HCA Healthcare's P/E ratio for today is 14.2. PE RATIO(14.2) = STOCK PRICE($429.19) / TTM EPS($30.23)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.